Neoadjuvant Immunotherapy for Resectable Gastric Cancer
Clinical trial NCT03878472 · COMPLETED
Trial details
- NCT number
- NCT03878472
- Sponsor
- Qilu Hospital of Shandong University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-01
- Primary completion
- 2022-06-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.